Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Testing the regulatory framework in South Africa – a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis

Fig. 2

Acceptability and preference of probiotics for vaginal health. At the final visit, participants completed a questionnaire to assess their (a) opinion about the oral/vaginal probiotic they used during the trial, (b) why their preferred the oral or vaginal application, (c) their perceived benefits and whether they would use it again or recommend it to another woman, (d) their application preference for the development of a future probiotic for vaginal health, (e) where they would want to buy it and (f) from whom they would like to get advice regarding the use of probiotics for vaginal health

Back to article page